The truth about delivering clinical research in the UK

• Are you looking to deliver your research in Europe?

• Need multiple, reliable sites in each country?

• Do you want to know why you should come to the UK?

In the past the UK’s reputation for delivering clinical research was questionable. But that’s all changed. Over the last five years the research landscape here has changed dramatically allowing us to make great strides in delivering research for the life-sciences industry. So whether you’re a small CRO, a medium med tech, or a pharma giant - we can help you.

The NIHR Clinical Research Network is hosting a live webinar which will explode common myths around the UK’s ability to deliver commercial clinical research.. This session will be hosted by Jonathan Sheffield, CEO of the NIHR Clinical Research Network. It will include performance data that will demonstrate why the UK should be your first choice for clinical research. You can find out:

• How much the UK’s market volume of commercial contract research (supported by the NIHR) has changed

• What percentage of the UK’s National Health Service (NHS) is actively delivering commercial contract research studies (with support from the NIHR)

• On average how many days it takes for NHS sites to get regulatory approval for research to take place (with NIHR support)

• What percentage of commercial contract studies (supported by the NIHR) are delivered to time and target

• How the NIHR is keeping clinical research in the public eye

• How the UK is sharpening its competitive edge by achieving more and more key first global patient milestones

Mar 4 2014

50 mins